CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 475 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,849,435 | -22.7% | 136,423 | -8.4% | 0.01% | -33.3% |
Q1 2024 | $10,151,887 | +283.5% | 148,942 | +252.2% | 0.01% | +200.0% |
Q4 2023 | $2,647,354 | -55.0% | 42,290 | -67.3% | 0.00% | -62.5% |
Q3 2023 | $5,878,096 | +98.2% | 129,502 | +145.1% | 0.01% | +100.0% |
Q2 2023 | $2,965,708 | +37.5% | 52,827 | +10.8% | 0.00% | +33.3% |
Q1 2023 | $2,156,431 | -41.2% | 47,677 | -47.2% | 0.00% | -50.0% |
Q4 2022 | $3,669,394 | -99.9% | 90,268 | +47.7% | 0.01% | 0.0% |
Q3 2022 | $3,994,519,000 | +1101.9% | 61,125 | +1017.7% | 0.01% | +500.0% |
Q2 2022 | $332,351,000 | -75.8% | 5,469 | -75.0% | 0.00% | -50.0% |
Q1 2022 | $1,374,224,000 | -28.9% | 21,893 | -14.2% | 0.00% | -33.3% |
Q4 2021 | $1,932,693,000 | +1372.0% | 25,504 | +2074.3% | 0.00% | – |
Q3 2021 | $131,294,000 | -30.1% | 1,173 | +1.1% | 0.00% | – |
Q2 2021 | $187,792,000 | +160.8% | 1,160 | +96.3% | 0.00% | – |
Q1 2021 | $72,013,000 | -96.8% | 591 | -96.0% | 0.00% | -100.0% |
Q4 2020 | $2,242,602,000 | +275.9% | 14,647 | +105.3% | 0.00% | +300.0% |
Q3 2020 | $596,604,000 | +28.4% | 7,133 | +12.8% | 0.00% | 0.0% |
Q2 2020 | $464,824,000 | -71.4% | 6,325 | -83.5% | 0.00% | -66.7% |
Q1 2020 | $1,626,593,000 | +2116.3% | 38,354 | +3082.9% | 0.00% | – |
Q4 2019 | $73,391,000 | -92.8% | 1,205 | -95.1% | 0.00% | -100.0% |
Q3 2019 | $1,015,814,000 | +2376.1% | 24,782 | +2745.2% | 0.00% | – |
Q2 2019 | $41,024,000 | – | 871 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |